Literature DB >> 12324564

Activated protein C for severe sepsis.

E Wesley Ely, Gordon R Bernard, Jean-Louis Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12324564     DOI： 10.1056/NEJM200209263471315

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  [Activated protein C. Inevitable in sepsis?].

Authors:  M Max
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Activated protein C: do more survive?

Authors:  Alasdair F Mackenzie
Journal:  Intensive Care Med       Date:  2005-10-15       Impact factor: 17.440

3.  Activated protein C: do more survive?

Authors:  Saxon Ridley
Journal:  Intensive Care Med       Date:  2006-03-01       Impact factor: 17.440

4.  Editors' comments on a new trial of activated protein C for persistent septic shock.

Authors:  Jordi Mancebo; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

5.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

6.  Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.

Authors:  Jean-François Dhainaut; Pierre-François Laterre; Jonathan M Janes; Gordon R Bernard; Antonio Artigas; Jan Bakker; Hanno Riess; Bruce R Basson; Julien Charpentier; Barbara G Utterback; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

7.  Interleukin 5 is protective during sepsis in an eosinophil-independent manner.

Authors:  Stefanie N Linch; Erin T Danielson; Ann M Kelly; Raina A Tamakawa; James J Lee; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2012-05-31       Impact factor: 21.405

8.  Advances in Sepsis Treatment.

Authors:  Todd W Rice; Gordon R Bernard
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

Review 9.  Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.

Authors:  S M Pastores
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

10.  Controversial treatment of a victim of severe head injury complicated by septic shock and acute respiratory distress syndrome.

Authors:  Anniken Haavind; Olav Hevrøy; Rune Hennig; Lars Bjertnaes
Journal:  Int Med Case Rep J       Date:  2011-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.